Guy Jérusalem
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 187
- Cancer Treatment and Pharmacology 79
- HER2/EGFR in Cancer Research 60
- Cancer Immunotherapy and Biomarkers 21
-
- Advanced Breast Cancer Therapies 98
- Co-authors
- Georges Fillet (27 shared papers)Yves Béguin (20 shared papers)Marie‐France Fassotte (15 shared papers)P. Rigo (8 shared papers)Fadi Najjar (8 shared papers)Patrick Paulus (8 shared papers)Joëlle Collignon (30 shared papers)Laurence Lousberg (3 shared papers)
- Journals
- Annals of Oncology (38 papers)Cancer Research (35 papers)Journal of Clinical Oncology (35 papers)Breast Cancer Research and Treatment (9 papers)BMC Cancer (7 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Guy Jérusalem
327 papers receiving 9.5k citations
Guy Jérusalem's Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 3.9k
- Cancer Research 1.5k
- Pulmonary and Respiratory Medicine 2.9k
- Pathology and Forensic Medicine 1.3k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by Guy Jérusalem
This map shows the geographic impact of Guy Jérusalem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Jérusalem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Jérusalem more than expected).
Fields of papers citing papers by Guy Jérusalem
This network shows the impact of papers produced by Guy Jérusalem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Jérusalem. The network helps show where Guy Jérusalem may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy Jérusalem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 342 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study Hit paper breakdown → | 2017 | 597 |
| 2 | Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2010 | 479 |
| 3 | 1999 | 465 | |
| 4 | Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy Hit paper breakdown → | 2020 | 351 |
| 5 | 2016 | 297 | |
| 6 | Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. | 2002 | 260 |
| 7 | 2013 | 249 | |
| 8 | 2001 | 225 | |
| 9 | 2002 | 176 | |
| 10 | 2018 | 175 | |
| 11 | Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. | 2001 | 175 |
| 12 | Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival Hit paper breakdown → | 2021 | 174 |
| 13 | 2015 | 146 | |
| 14 | 2021 | 142 | |
| 15 | 2016 | 140 | |
| 16 | 1999 | 133 | |
| 17 | 2019 | 125 | |
| 18 | 2010 | 114 | |
| 19 | 2014 | 113 | |
| 20 | 2011 | 112 |
About Guy Jérusalem
Guy Jérusalem is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 342 papers that have together received 9.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (98 papers), Cancer Treatment and Pharmacology (79 papers), HER2/EGFR in Cancer Research (60 papers), Breast Cancer Treatment Studies (30 papers), Medical Imaging Techniques and Applications (27 papers), PI3K/AKT/mTOR signaling in cancer (22 papers), Lymphoma Diagnosis and Treatment (22 papers) and Cancer Immunotherapy and Biomarkers (21 papers). The work is most often cited by research in Oncology (3.9k citations), Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (2.9k citations), Pathology and Forensic Medicine (1.3k citations) and Radiology, Nuclear Medicine and Imaging (1.5k citations). Guy Jérusalem has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Georges Fillet, Yves Béguin, Marie‐France Fassotte, P. Rigo, Fadi Najjar, Patrick Paulus, Joëlle Collignon, Laurence Lousberg, Hélène Schroeder and R. Hustinx. Their work appears in journals such as Annals of Oncology, Cancer Research, Journal of Clinical Oncology, Breast Cancer Research and Treatment and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.